Careteq (ASX:CTQ) Market Cap: A$8.80 Mil (As of Jul. 04, 2026)


What is Careteq Market Cap?

Careteq ASX:CTQ Market Cap is A$8.80 Mil as of Jul. 04, 2026. The stock has 8 warning signs investors should review. Among 695 Healthcare Providers & Services companies, Careteq ranks worse than 88.35% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Careteq's share price for the quarter that ended in Dec. 2025 was A$0.011. Careteq's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 237.12 Mil. Therefore, Careteq's market cap for the quarter that ended in Dec. 2025 was A$2.61 Mil.

Careteq's quarterly market cap increased from Dec. 2024 (A$2.37 Mil) to Jun. 2025 (A$2.61 Mil) but then stayed the same from Jun. 2025 (A$2.61 Mil) to Dec. 2025 (A$2.61 Mil).

Careteq's annual market cap declined from Jun. 2023 (A$4.32 Mil) to Jun. 2024 (A$3.08 Mil) and declined from Jun. 2024 (A$3.08 Mil) to Jun. 2025 (A$2.61 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Careteq's Enterprise Value for Today is A$10.12 Mil.


Careteq  (ASX:CTQ) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Careteq Market Cap Related Terms


Careteq Market Cap Historical Data

* Premium members only.

The historical data trend for Careteq's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Careteq Market Cap Chart

Careteq Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Market Cap
0.00 9.76 4.32 3.08 2.61

Careteq Semi-Annual Data
Jun21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Market Cap Get a 7-Day Free Trial Premium Member Only 6.83 3.08 2.37 2.61 2.61

ASX:CTQ vs VEEV, BTSG, TEM: Market Cap Comparison

For the Health Information Services subindustry, Careteq's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Careteq Market Cap vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Careteq's Market Cap distribution charts can be found below:

* The bar in red indicates where Careteq's Market Cap falls into.



Careteq Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Careteq's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as

Market Cap (A: Jun. 2025 )=Share Price (A: Jun. 2025 )*Shares Outstanding (EOP) (A: Jun. 2025 )
=A$0.011*237.119
=A$2.61

Careteq's Market Cap for the quarter that ended in Dec. 2025 is calculated as

Market Cap (Q: Dec. 2025 )=Share Price (Q: Dec. 2025 )*Shares Outstanding (EOP) (Q: Dec. 2025 )
=A$0.011*237.119
=A$2.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of A$8.80 Mil mean?
Careteq (ASX:CTQ) has a Market Cap of A$8.80 Mil as of Jul. 04, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Careteq and its competitors. According to the industry distribution chart, Careteq ranks #614 out of 695 companies in the Healthcare Providers & Services industry, placing it in the top 88.3%.
Is Careteq's Market Cap too high?
Careteq's current Market Cap is A$8.80 Mil. Based on the distribution chart, Careteq ranks #614 out of 695 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Careteq's Market Cap compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Careteq ranks #614 out of 695 companies for Market Cap. This places Careteq in the lower half of its industry. The industry median Market Cap is 97.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 97.60, based on 695 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Careteq and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 97.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Careteq's current Market Cap is A$8.80 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Careteq stock overvalued right now?
Based on GuruFocus' analysis, Careteq (ASX:CTQ) is currently considered Modestly Overvalued. The stock's GF Value™ is A$0.01, compared to a current price of A$0.01 — trading 20% above its estimated fair value. The current Market Cap is A$8.80 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Careteq (ASX:CTQ), the current Market Cap is A$8.80 Mil as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Careteq Business Description

Address 99 Queen Street, Level 10, Melbourne, VIC, AUS, 3000
Careteq Ltd provides Residential Medication Management Review and Home Medicines Review services as part of the Medication Management Programs, generating revenue from medication review, education, and support services. The company focuses on medication management and home care solutions to provide continuity of care and improve clinical outcomes for patients through Home Medication Reviews. Medication-related harm includes adverse drug reactions, medication errors, and complications that jeopardise patient safety and increase healthcare costs. The company operates in Australia.